Enteral Nutrition Market Progress: Innovations in Nutritional Support
Posted by Roger on January 4th, 2024
Enteral nutrition products are primarily used in tube feeding systems such as feeding pumps and feeding tubes for delivering nutritional requirements to patients suffering from chronic diseases or severe health conditions where oral feeding is not possible. Enteral feeding tubes help provide nutrition support to people who cannot obtain nutrition through normal eating. The global enteral nutrition market involves a wide range of products like tube feeding, formulas, administration sets, and pumps. The market is estimated to be valued at US$ 3.01 Bn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising Incidence of Chronic Diseases
The rise in chronic diseases globally is one of the major drivers propelling growth of the enteral nutrition market. Diseases such as cancer, gastrointestinal disorders, neurological disorders, and diabetes have significant impact on nutritional status of patients. Malnutrition associated with chronic diseases can worsen the patient's health condition. Enteral nutrition helps improve the nutritional status and clinical outcomes of patients suffering from chronic diseases.
Another driver expanding the market is growing geriatric population worldwide who are more prone to health conditions requiring nutritional support. Aging diminishes swallowing ability and increases risk of conditions such as dysphagia and dementia where tube feeding is essential. Overall, the surging prevalence of chronic diseases and aging demographics demanding nutritional interventions augur well for the enteral nutrition market over the forecast period.
SWOT Analysis
Strength: Enteral nutrition offers nutritional support to patients who are unable to meet their nutritional needs through oral diet. It provides balance nutrition to the patients increasing their health and recovery. It also helps prevent malnutrition and improves health outcomes.
Weakness: Enteral tubes require skilled nurses for insertion and ongoing care. This increases healthcare costs. Many patients find enteral tubes uncomfortable leading to reduced compliance.
Opportunity: Rising prevalence of chronic diseases and conditions increasing the risk of malnutrition presents an opportunity. Growing elderly population worldwide also increases the target population requiring nutritional support. Technological advancements are improving products and making administration easier.
Threats: High costs of products threatens widespread adoption. Reimbursement policies also vary limiting product access in some regions. Substitutes like parenteral nutrition hold competition in certain conditions.
Key Takeaways
The global enteral nutrition market is expected to witness high growth over the forecast period aided by increasing chronic disease burden worldwide.
The regional analysis indicates North America currently dominating the market due to advanced healthcare systems and supportive reimbursement policies increasing adoption rates. Europe is also a major market. However, Asia Pacific is poised to offer greatest growth potential owing to improving access to healthcare systems, rising healthcare expenditure and massive target populations in countries like China and India.
Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP. They are focusing on product innovations and expansions to capitalize on opportunities. For instance, Fresenius Kabi launched Vital specific in 2020 to provide complete and optimized nutrition.
